medicaid glp 1 Medicare, will cover GLP-1 weight-loss drugs next year GLP-1s prescriptions for weight loss

While compounded semaglutide may be appropriate in rare, clinically justified situations, FDA-approved medications remain the preferred standard

This exceeds the maximum weight loss seen with semaglutide at its highest dose (14.9% at 68 weeks)

Protocols should specify how long reconstituted solutions remain stable, how waste is disposed of, and how data will be recorded to prevent selective reporting

Companies such as Ozempic and Wegovy manufacturer Novo Nordisk and Mounjaro manufacturer Eli Lilly publicly reached deals with the Trump administration to lower the cost of their blockbuster weight loss drugs for patients paying with cash or using insurance, including Medicare and Medicaid